Mamaearth Parent Jumps 10% How a Brand Comeback After a Tough Phase Rewards Patient Investors

$HONASA Honasa Consumer parent of Mamaearth and The Derma Co surged 10.4% to ₹398 on NSE after posting its highest ever quarterly revenue and EBITDA in Q4 FY26. Jefferies maintained a Buy rating with a target of ₹565 calling the company firmly on a strong growth path. Just a few quarters ago Honasa was struggling. The company went through a painful distribution realignment restructuring how its products reached retail shelves across India. This caused a temporary revenue slowdown and worried investors. But management held their nerve, fixed the distribution network and came out stronger. Q4 FY26 is proof record revenue, record EBITDA and profits doubling. This is a classic business turnaround rewarding patient investors When a consumer brand shifts from one distribution model to another say from wholesale to direct retail there is a temporary disruption. Fewer products reach shelves, sales dip and investors panic. But once the new system kicks in revenue accelerates faster than before. Honasa just proved this. Mamaearth scaling up → Core brand growing at mid-teens a healthy rate for a maturing brand. Younger brands gaining traction → The Derma Co and other newer brands are scaling rapidly creating future revenue engines beyond Mamaearth. Guidance for high-teens growth → Management guided for high-teens revenue growth with 100 basis points margin expansion in FY27 a confident and ambitious outlook. Honasa Consumer's 10% rally after posting record revenue and doubling profits teaches investors that consumer brands going through temporary distribution challenges can emerge significantly stronger, and that tracking revenue momentum across multiple brands alongside EBITDA margin improvement is essential for identifying whether a D2C consumer company's growth story is genuinely back on track before making an investment decision. $NYKAA $HINDUNILVR